The vision of the leadership of Duke University Medical Center and the Duke Comprehensive Cancer Center is to create an academic environment in which the mission of clinical oncology research is valued highly, its methodology is considered an evolving work in progress, and interactions between biomedical scientists and health professionals are fostered in such a way as to transform fundamental discoveries in the laboratory into medical care that promotes and preserves human health. We propose a Clinical Oncology Research Career Development Program (CORCDP) to create a system in which senior faculty representing the disparate disciplines of discovery science, translational research, and clinical trials will unite in an effort to create an integrated research system. Our proposed CORCDP has five major elements. First, each trainee will have a formal multi-disciplinary didactic program using coursework taught as part of the Masters of Health Sciences degree at Duke. Second, in addition to learning through coursework, successful future clinical investigators must have high-quality mentoring and opportunities to do significant original work so that they can eventually move to an independent, sustainable academic career. Each trainee supported by this CORCDP will be required to conduct 3 years of full-time research under the direction of a Lead Mentor in medical oncology, surgical oncology, gynecologic oncology, or radiation oncology. Third, each trainee will have a three-month internship rotation through the NCI Cancer Treatment Evaluation Program (CTEP) in Rockville, MD to gain insights and experience in some of the key activities along the spectrum of patient-oriented research. Fourth, each trainee will receive formal instruction in the """"""""survival skills"""""""" essential to a successful academic career, such as medical writing, public speaking, and grant preparation. Finally, each trainee will undergo formal and rigorous training in the responsible conduct of research. The proposed CORCDP will organize the abundant resources available at Duke for clinical research into a focused and efficient program for training the clinical oncology research thought leaders of the future.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
1K12CA100639-01A1
Application #
6764883
Study Section
Special Emphasis Panel (ZCA1-RTRB-Z (J1))
Program Officer
Lei, Ming
Project Start
2004-08-04
Project End
2009-07-31
Budget Start
2004-08-04
Budget End
2005-07-31
Support Year
1
Fiscal Year
2004
Total Cost
$487,219
Indirect Cost
Name
Duke University
Department
Surgery
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Kim, Jihee; Grotegut, Chad A; Wisler, James W et al. (2018) ?-arrestin 1 regulates ?2-adrenergic receptor-mediated skeletal muscle hypertrophy and contractility. Skelet Muscle 8:39
Mackie, Duncan I; Al Mutairi, Fuad; Davis, Reema B et al. (2018) hCALCRL mutation causes autosomal recessive nonimmune hydrops fetalis with lymphatic dysplasia. J Exp Med 215:2339-2353
Crosby, Erika J; Wei, Junping; Yang, Xiao Yi et al. (2018) Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors. Oncoimmunology 7:e1421891
Snyder, Joshua C; Rochelle, Lauren K; Ray, Caroline et al. (2017) Inhibiting clathrin-mediated endocytosis of the leucine-rich G protein-coupled receptor-5 diminishes cell fitness. J Biol Chem 292:7208-7222
Zhu, Lu; Rossi, Mario; Cui, Yinghong et al. (2017) Hepatic ?-arrestin 2 is essential for maintaining euglycemia. J Clin Invest 127:2941-2945
Bhattacharyya, Jayanta; Ren, Xiu-Rong; Mook, Robert A et al. (2017) Niclosamide-conjugated polypeptide nanoparticles inhibit Wnt signaling and colon cancer growth. Nanoscale 9:12709-12717
Mook Jr, Robert A; Ren, Xiu-Rong; Wang, Jiangbo et al. (2017) Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/?-catenin signaling with selectivity over effects on ATP homeostasis. Bioorg Med Chem 25:1804-1816
Kanju, Patrick; Chen, Yong; Lee, Whasil et al. (2016) Small molecule dual-inhibitors of TRPV4 and TRPA1 for attenuation of inflammation and pain. Sci Rep 6:26894
Urs, Nikhil M; Gee, Steven M; Pack, Thomas F et al. (2016) Distinct cortical and striatal actions of a ?-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties. Proc Natl Acad Sci U S A 113:E8178-E8186
Snyder, Joshua C; Pack, Thomas F; Rochelle, Lauren K et al. (2015) A rapid and affordable screening platform for membrane protein trafficking. BMC Biol 13:107

Showing the most recent 10 out of 38 publications